Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression

Biological Chemistry

Volumn 392, Issue 5, 2011, Pages 439-448

  Maritz, Michelle F ^a   Van Der Watt, Pauline J ^a   Holderness, Nina ^a   Birrer, Michael J ^b   Leaner, Virna D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AP 1; cervical cancer; p21; Tam67

Indexed keywords

PROTEIN C JUN; PROTEIN P21; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR TAM67; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HELA CELLS; HUMANS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-1; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 79953839326     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.036     Document Type: Article

References (51)

1. Angel, P. and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Bio-phys. Acta 1072, 129-157. (Pubitemid 121007534)
2. Angel, P., Allegretto, E.A., Okino, S.T., Hattori, K., Boyle, WJ., Hunter, T., and Karin, M. (1988). Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332, 166-171. (Pubitemid 18083563)
3. Bamberger, A.M., Milde-Langosch, K., Rossing, E., Goemann, C., and Loning, T. (2001). Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J. Cancer Res. Clin. Oncol. 127, 545-550. (Pubitemid 32757488)
4. 2/M cell cycle transition. FEBS Lett. 444, 32-37. (Pubitemid 29094634)
5. Berger, I. and Shaul, Y. (1998). c-Fos antagonizes the junD gene positive autoregulatory loop; a novel c-Fos role in promoter switching. Gene 211, 375-382. (Pubitemid 28230350)
6. Bos, TJ., Monteclaro, F.S., Mitsunobu, F., Ball, A.R. Jr., Chang, C.H., Nishimura, T., and Vogt, P.K. (1990). Efficient transfor-mation of chicken embryo fibroblasts by c-Jun requires struc-tural modification in coding and noncoding sequences. Genes Dev. 4, 1677-1687.
7. Brown, P.H., Alani, R., Preis, L.H., Szabo, E., and Birrer, M.J. (1993). Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8, 877-886. (Pubitemid 23087418)
8. Brown, P.H., Chen, T.K., and Birrer, MJ. (1994). Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9, 791-799. (Pubitemid 24065917)
9. Brown, P.H., Kim, S.H., Wise, S.C., Sabichi, A.L., and Birrer, M.J. (1996). Dominant-negative mutants ofcJun inhibit AP-1 activity through multiple mechanisms and with different potencies. Cell Growth Differ. 7, 1013-1021. (Pubitemid 26360712)
10. Chan, W.K., Chong, T., Bernard, H.U., and Klock, G. (1990). Tran-scription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res. 18, 763-769.
11. Chong, T., Apt, D., Gloss, B., Isa, M., and Bernard, H.U. (1991). The enhancer of human papillomavirus type 16: Binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. J. Virol. 65, 5933-5943.
12. 2/M arrest in a p53-deficient human lung cancer cell. Biochem. Biophys. Res. Commun. 293, 1248-1253.
13. de Wilde, J., De-Castro, AJ., Snijders, PJ., Meijer, CJ., Rosl, F., and Steenbergen, R.D. (2008). Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol. 30, 77-87. (Pubitemid 351161039)
14. 2/M-phase transition. Mol. Cell Biol. 18, 546-557. (Pubitemid 28021065)
15. 2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner. Eur. J Cancer 42, 422-426. (Pubitemid 43132900)
16. Eferl, R. and Wagner, E.F. (2003). AP-1: A double-edged sword in tumorigenesis. Nat Rev. Cancer 3, 859-868. (Pubitemid 37383716)
17. Glover, J.N. and Harrison, S.C. (1995). Crystal structure of the hete-rodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257-261.
18. Hartl, M., Bader, A.G., and Bister, K. (2003). Molecular targets of the oncogenic transcription factor jun. Curr. Cancer Drug Targets 3, 41-55. (Pubitemid 36119420)
19. Hennigan, R.F. and Stambrook, PJ. (2001). Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase com-plexes. Mol. Biol. Cell 12, 2352-2363. (Pubitemid 33051961)
20. Joyce, D., Albanese, C., Steer, J., Fu, M., Bouzahzah, B., and Pes-tell, R.G. (2001). NF-κB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12, 73-90. (Pubitemid 32294588)
21. Karin, M., Liu, Z., and Zandi, E. (1997). AP-1 function and regu-lation. Curr. Opin. Cell Biol. 9, 240-246.
22. Katabami, M., Donninger, H., Hommura, F., Leaner, V.D., Kinos-hita, I., Chick, J.F., and Birrer, MJ. (2005). Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-inde-pendent growth in RAT1a cells. J. Biol. Chem. 280, 16728-16738. (Pubitemid 41389130)
23. Kielosto, M., Nummela, P., Katainen, R., Leaner, V, Birrer, MJ., and Holtta, E. (2004). Reversible regulation of the transformed phenotype of ornithine decarboxylase-and ras-overexpressing cells by dominant-negative mutants of c-Jun. Cancer Res. 64, 3772-3779. (Pubitemid 38697286)
24. Kinoshita, I., Leaner, V, Katabami, M., Manzano, R.G., Dent, P., Sabichi, A., and Birrer, M.J. (2003). Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth. Oncogene 22, 2710-2722. (Pubitemid 36609586)
25. Kovary, K. and Bravo, R. (1991). The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell Biol. 11, 4466-4472. (Pubitemid 21895842)
26. Kyo, S., Klumpp, DJ., Inoue, M., Kanaya, T., and Laimins, L.A. (1997). Expression of AP1 during cellular differentiation deter-mines human papillomavirus E6/E7 expression in stratified epi-thelial cells. J. Gen. Virol. 78, 401-411. (Pubitemid 27075638)
27. Leaner, V.D., Donninger, H., Ellis, C.A., Clark, GJ., and Birrer, M.J. (2005). p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up reg-ulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. Mol. Cell Biol. 25, 3324-3337. (Pubitemid 40464332)
28. Li, Y., Jenkins, C.W., Nichols, M.A., and Xiong, Y. (1994). Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9, 2261-2268. (Pubitemid 24228676)
29. Li, JJ., Rhim, J.S., Schlegel, R., Vousden, K.H., and Colburn, N.H. (1998). Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorageinde-pendent growth of HPV immortalized human keratinocytes. Oncogene 16, 2711-2721. (Pubitemid 28279336)
30. Li, JJ., Cao, Y., Young, M.R., and Colburn, N.H. (2000). Induced expression of dominant-negative c-jun downregulates NF-κB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol. Carcinog. 29, 159-169.
31. Liu, Y., Ludes-Meyers, J., Zhang, Y., Munoz-Medellin, D., Kim, H.T., Lu, C., Ge, G., Schiff, R., Hilsenbeck, S.G., Osborne, C.K., et al. (2002). Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 21, 7680-7689. (Pubitemid 35398814)
32. Neyns, B., Teugels, E., Bourgain, C., Birrerand, M., and De, GJ. (1999). Alteration of jun proto-oncogene status by plasmid trans-fection affects growth of human ovarian cancer cells. Int. J. Cancer 82, 687-693. (Pubitemid 29356967)
33. Plaisance, S., Vanden, B.W., Boone, E., Fiers, W., and Haegeman, G. (1997). Recombination signal sequence binding protein Jkap-pa is constitutively bound to the NF-κB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell Biol. 17, 3733-3743. (Pubitemid 27281848)
34. Prusty, B.K. and Das, B.C. (2005). Constitutive activation oftran-scription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int. J. Cancer 113, 951-960. (Pubitemid 40096875)
35. Rapp, U.R., Troppmair, J., Beck, T., and Birrer, MJ. (1994). Trans-formation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene 9, 3493-3498. (Pubitemid 24359386)
36. Risse-Hackl, G., Adamkiewicz, J., Wimmel, A., and Schuermann, M. (1998). Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruit-ment of specific AP-1 proteins. Oncogene 16, 3057-3068. (Pubitemid 28297728)
37. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, AJ., and Howley, P.M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation ofp53. Cell 63, 1129-1136. (Pubitemid 120035062)
38. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., and Wagner, E.F. (1999). Con-trol of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607-619. (Pubitemid 29131884)
39. Schutte, J., Viallet, J., Nau, M., Segal, S., Fedorko, J., and Minna, J. (1989). Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59, 987-997. (Pubitemid 20024610)
40. Shaulian, E. and Karin, M. (2002). AP-1 as a regulator of cell life and death. Nat Cell Biol. 4, E131-E136. (Pubitemid 34521026)
41. Shimizu, Y., Kinoshita, I., Kikuchi, J., Yamazaki, K., Nishimura, M., Birrer, M.J., and aka-Akita, H. (2008). Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. Br. J. Cancer 98, 915-922. (Pubitemid 351341616)
42. Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M., and Karin, M. (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494-496. (Pubitemid 21896867)
43. Smith, L.M., Wise, S.C., Hendricks, D.T., Sabichi, A.L., Bos, T., Reddy, P., Brown, P.H., and Birrer, M.J. (1999). cJun overex-pression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18, 6063-6070. (Pubitemid 29535018)
44. Suzuki, T., Murakami, M., Onai, N., Fukuda, E., Hashimoto, Y., Sonobe, M.H., Kameda, T., Ichinose, M., Miki, K., and Iba, H. (1994). Analysis of AP-1 function in cellular transformation pathways. J. Virol. 68, 3527-3535. (Pubitemid 24177376)
45. van Dam, H. and Castellazzi, M. (2001). Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 20, 2453-2464. (Pubitemid 32531302)
46. Vleugel, M.M., Greijer, A.E., Bos, R., van der, W.E., and van Diest, PJ. (2006). c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol. 37, 668-674. (Pubitemid 43956532)
47. Wang, H.L., Wang, J., Xiao, S.Y., Haydon, R., Stoiber, D., He, T.C., Bissonnette, M., and Hart, J. (2002). Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing β-catenin. Int. J. Cancer 101, 301-310. (Pubitemid 34983184)
48. Watsuji, T., Okamoto, Y., Emi, N., Katsuoka, Y., and Hagiwara, M. (1997). Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. Biochem. Biophys. Res. Commun. 234, 769-773. (Pubitemid 27281195)
49. 2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells. Am. J. Physiol. Cell. Physiol. 294, C1342-C1349.
50. Young, M.R., Farrell, L., Lambert, P., Awasthi, P., and Colburn, N.H. (2002). Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dom-inant-negative c-jun. Mol. Carcinog. 34, 72-77. (Pubitemid 34606509)
51. Young, M.R., Li, J.J., Rincon, M., Flavell, R.A., Sathyanarayana, B.K., Hunziker, R., and Colburn, N. (1999). Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA 96, 9827-9832. (Pubitemid 29398817)